SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19735233
Source:
http://linkedlifedata.com/resource/pubmed/id/19735233
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008976
,
umls-concept:C0036043
,
umls-concept:C0205314
,
umls-concept:C0358591
,
umls-concept:C0524527
,
umls-concept:C0596545
,
umls-concept:C0679622
,
umls-concept:C1554184
,
umls-concept:C1707664
,
umls-concept:C1979963
,
umls-concept:C2003903
,
umls-concept:C2348248
,
umls-concept:C2348867
pubmed:issue
10
pubmed:dateCreated
2009-10-27
pubmed:abstractText
Dexlansoprazole MR is a dual delayed release formulation of dexlansoprazole, an enantiomer of lansoprazole.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8707234
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/2-Pyridinylmethylsulfinylbenzimidazo...
,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations
,
http://linkedlifedata.com/resource/pubmed/chemical/Proton Pump Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/lansoprazole
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1365-2036
pubmed:author
pubmed-author:AtkinsonS NSN
,
pubmed-author:DabholkarA HAH
,
pubmed-author:MetzD CDC
,
pubmed-author:ParisM MMM
,
pubmed-author:PeuraD ADA
,
pubmed-author:YuPP
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1010-21
pubmed:meshHeading
pubmed-meshheading:19735233-2-Pyridinylmethylsulfinylbenzimidazoles
,
pubmed-meshheading:19735233-Adult
,
pubmed-meshheading:19735233-Aged
,
pubmed-meshheading:19735233-Aged, 80 and over
,
pubmed-meshheading:19735233-Anti-Ulcer Agents
,
pubmed-meshheading:19735233-Clinical Trials as Topic
,
pubmed-meshheading:19735233-Delayed-Action Preparations
,
pubmed-meshheading:19735233-Female
,
pubmed-meshheading:19735233-Gastroesophageal Reflux
,
pubmed-meshheading:19735233-Humans
,
pubmed-meshheading:19735233-Male
,
pubmed-meshheading:19735233-Middle Aged
,
pubmed-meshheading:19735233-Proton Pump Inhibitors
,
pubmed-meshheading:19735233-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience.
pubmed:affiliation
University of Virginia Health Sciences Center, Charlottesville, VA, USA. dap8v@virginia.edu
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't